OAM
AMRX icon

Oppenheimer Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Oppenheimer Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-38
Closed – – 1602
2019
Q2 		$0 Sell
38
-18,231
-100% -$186K ﹤0.01% 1621
2019
Q1 		$259K Buy
18,269
+1,828
+11% +$24.2K 0.01% 965
2018
Q4 		$222K Sell
16,441
-4,933
-23% -$88.9K 0.01% 983
2018
Q3 		$474K Buy
21,374
+921
+5% +$19.4K 0.01% 832
2018
Q2 		$336K Buy
+20,453
New +$359K 0.01% 900

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Oppenheimer Asset Management's AMRX Position: Q3 2019 in Review

Oppenheimer Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2019, closing a stake of 38 shares.

Oppenheimer Asset Management first reported a position in AMRX in Q2 2018 and held it in 5 quarters. The position peaked at $474K in Q3 2018. 121 funds tracked by Wall St. Rank hold AMRX as of Q3 2019.

  • Oppenheimer Asset Management reported no remaining Amneal Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Oppenheimer Asset Management sold 38 Amneal Pharmaceuticals shares in Q3 2019.
  • Oppenheimer Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Oppenheimer Asset Management's Amneal Pharmaceuticals position peaked at $474K in Q3 2018.
  • 121 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2019.

Based on Oppenheimer Asset Management's 13F filing for Q3 2019, filed 31 Oct 2019.